Mini Review
Published on 02 Oct 2023
The interplay of FLT3 and CXCR4 in acute myeloid leukemia: an ongoing debate
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1258679
- 1,631 views
- 1 citation
Type at least 3 characters
1,687 articles
Articles
Case Report
Published on 02 Oct 2023
Case Report: A recurrent case of ALK-ALCL after autologous transplantation was successfully treated with BV + a modified CHEP chemotherapy containing mitoxantrone hydrochloride liposome with the addition of chidamide maintenance therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1242552
- 1,389 views
Review
Published on 02 Oct 2023
Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1240966
- 3,012 views
- 2 citations
Case Report
Published on 29 Sep 2023
Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1266996
- 1,780 views
- 1 citation
Mini Review
Published on 29 Sep 2023
Biological insights into the role of TET2 in T cell lymphomas
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1199108
- 1,868 views
Original Research
Published on 27 Sep 2023
High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1250355
- 1,939 views
- 4 citations
Review
Published on 26 Sep 2023
Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1127407
- 2,355 views
- 4 citations
Original Research
Published on 25 Sep 2023
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1218989
- 2,340 views
- 2 citations
Review
Published on 22 Sep 2023
Updates in pathobiological aspects of anaplastic large cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1241532
- 2,830 views
- 2 citations
Original Research
Published on 20 Sep 2023
The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1266868
- 1,196 views
- 2 citations
Original Research
Published on 19 Sep 2023
Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1264422
- 2,315 views
Original Research
Published on 18 Sep 2023
Evaluation of factors leading to poor outcomes for pediatric acute lymphoblastic leukemia in Mexico: a multi-institutional report of 2,116 patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1255555
- 2,702 views
- 3 citations
Review
Published on 14 Sep 2023
Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1240359
- 2,073 views
Brief Research Report
Published on 13 Sep 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1264387
- 1,575 views
- 1 citation
Case Report
Published on 13 Sep 2023
Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1248964
- 1,364 views
- 1 citation
Original Research
Published on 12 Sep 2023
Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & SocietĂ Italiana della Riproduzione Umana
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1252433
- 2,258 views
- 1 citation